Allscripts (MDRX) Tops Q1 EPS by 4c; Provides FY21 Revenues Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Allscripts Announces First Quarter 2021 Results
April 29, 2021 4:01 PM EDTFirst quarter GAAP EPS of $0.06; non-GAAP diluted EPS of $0.19 First quarter bookings of $194 million up 6% from the first quarter of 2020 Generated $56 million of cash flow from continuing operations and $35 million of free cash flow in the first quarter
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2021.
Bookings(1) were $194 million in the first quarter of 2021. This result compares with $183 million in the first quarter of 2020. Contract revenue backlog... More
